» Articles » PMID: 33811820

Oxylipin Biosynthesis Reinforces Cellular Senescence and Allows Detection of Senolysis

Abstract

Cellular senescence is a stress or damage response that causes a permanent proliferative arrest and secretion of numerous factors with potent biological activities. This senescence-associated secretory phenotype (SASP) has been characterized largely for secreted proteins that participate in embryogenesis, wound healing, inflammation, and many age-related pathologies. By contrast, lipid components of the SASP are understudied. We show that senescent cells activate the biosynthesis of several oxylipins that promote segments of the SASP and reinforce the proliferative arrest. Notably, senescent cells synthesize and accumulate an unstudied intracellular prostaglandin, 1a,1b-dihomo-15-deoxy-delta-12,14-prostaglandin J2. Released 15-deoxy-delta-12,14-prostaglandin J2 is a biomarker of senolysis in culture and in vivo. This and other prostaglandin D2-related lipids promote the senescence arrest and SASP by activating RAS signaling. These data identify an important aspect of cellular senescence and a method to detect senolysis.

Citing Articles

Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques.

Pratsinis H, Mavrogonatou E, Zervou S, Triantis T, Hiskia A, Kletsas D Methods Mol Biol. 2025; 2906:315-359.

PMID: 40082365 DOI: 10.1007/978-1-0716-4426-3_19.


Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective.

Wang Z, Zhu H, Xiong W Front Med. 2025; .

PMID: 39821730 DOI: 10.1007/s11684-024-1116-0.


The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities.

Wang Z, Chen C, Ai J, Gao Y, Wang L, Xia S MedComm (2020). 2025; 6(1):e70048.

PMID: 39811803 PMC: 11731108. DOI: 10.1002/mco2.70048.


Emerging insights in senescence: pathways from preclinical models to therapeutic innovations.

Mansfield L, Ramponi V, Gupta K, Stevenson T, Mathew A, Barinda A NPJ Aging. 2024; 10(1):53.

PMID: 39578455 PMC: 11584693. DOI: 10.1038/s41514-024-00181-1.


Senescence as a therapeutic target in cancer and age-related diseases.

McHugh D, Duran I, Gil J Nat Rev Drug Discov. 2024; 24(1):57-71.

PMID: 39548312 DOI: 10.1038/s41573-024-01074-4.


References
1.
Buratta S, Urbanelli L, Sagini K, Giovagnoli S, Caponi S, Fioretto D . Extracellular vesicles released by fibroblasts undergoing H-Ras induced senescence show changes in lipid profile. PLoS One. 2017; 12(11):e0188840. PMC: 5705128. DOI: 10.1371/journal.pone.0188840. View

2.
BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

3.
Dagouassat M, Gagliolo J, Chrusciel S, Bourin M, Duprez C, Caramelle P . The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2013; 187(7):703-14. DOI: 10.1164/rccm.201208-1361OC. View

4.
Hernandez-Segura A, de Jong T, Melov S, Guryev V, Campisi J, Demaria M . Unmasking Transcriptional Heterogeneity in Senescent Cells. Curr Biol. 2017; 27(17):2652-2660.e4. PMC: 5788810. DOI: 10.1016/j.cub.2017.07.033. View

5.
Perretti M, DAcquisto F . Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2008; 9(1):62-70. DOI: 10.1038/nri2470. View